Stock Taper
EXCHANGE TRADED FUND

IBRN

iShares Neuroscience and Healthcare ETF
$39.06 ▼ 0.80%
−$0.31 TODAY

FUND FACTS

Manager IShares
Assets $7.8M
Expense ratio 0.47%
Inception Aug 23, 2022
Asset class Equity
Holdings 52
Volume 1.08K
Avg volume 2.8K

ABOUT THIS FUND

The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U.S. and from other countries, that are expected to benefit from new discoveries and the overall growth in the field of neuroscience.

PRICE

$39.06 ▼ DOWN 0.80% (−$0.31)
$39.00$39.08$39.159:30 AM10:34 AM11:38 AM12:42 PM1:47 PM2:51 PM3:55 PM39.06

HOLDINGS

TOP 20 OF 52 · 72.51% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
02 DNTH Dianthus Therapeutics, Inc. 5.02% 3.65K $393.87K
04 ACAD ACADIA Pharmaceuticals Inc. 4.71% 13.27K $369.56K
06 ARGX argenx SE 4.43% 330 $347.64K
07 XENE Xenon Pharmaceuticals Inc. 4.37% 5.68K $343.37K
08 BIIB Biogen Inc. 4.30% 1.5K $337.89K
09 ALKS Alkermes plc 4.10% 6.87K $322.06K
10 PTCT PTC Therapeutics, Inc. 3.77% 4.14K $295.95K
11 NBIX Neurocrine Biosciences, Inc. 3.62% 1.79K $283.92K
12 DNLI Denali Therapeutics Inc. 3.39% 11.67K $265.98K
13 AXSM Axsome Therapeutics, Inc. 3.36% 1.26K $263.56K
14 DYN Dyne Therapeutics, Inc. 3.29% 10.35K $258.28K
15 EWTX Edgewise Therapeutics, Inc. 3.29% 6.15K $258.12K
16 AXGN AxoGen, Inc. 2.43% 4.05K $190.94K
18 SRPT Sarepta Therapeutics, Inc. 2.32% 7.94K $182.49K
19 BHVN Biohaven Ltd. 1.99% 9.84K $156K

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 73.19% OF THE FUND
United States 73.19%
Ireland 4.55%
Netherlands 4.43%
Canada 4.37%
South Korea 2.59%
Sweden 2.34%
Denmark 1.85%
Australia 1.62%
Switzerland 1.57%
China 1.00%
Japan 1.00%
France 0.63%
Israel 0.42%
Italy 0.28%
Other 0.16%